Rathbones Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Sell
37,447
-2,324
-6% -$1.17M 0.07% 133
2025
Q4
$18.6M Sell
39,771
-5,532
-12% -$2.57M 0.07% 134
2025
Q3
$19.3M Sell
45,303
-3,847
-8% -$1.49M 0.08% 130
2025
Q2
$18.8M Sell
49,150
-101
-0.2% -$36.4K 0.08% 131
2025
Q1
$17M Buy
49,251
+934
+2% +$300K 0.08% 135
2024
Q4
$14.5M Buy
48,317
+787
+2% +$275K 0.07% 141
2024
Q3
$19.3M Sell
47,530
-725
-2% -$265K 0.1% 122
2024
Q2
$15.5M Buy
48,255
+879
+2% +$286K 0.08% 130
2024
Q1
$15.8M Sell
47,376
-1,333
-3% -$407K 0.09% 127
2023
Q4
$13.2M Buy
48,709
+1,112
+2% +$275K 0.09% 130
2023
Q3
$11.7M Buy
+47,597
New +$13M 0.08% 133

Other funds holding HCA

Rathbones Group's HCA Position: Q1 2026 in Review

Rathbones Group reduced its HCA Healthcare (HCA) stake by 5.8% in Q1 2026, selling an estimated $1.17M and leaving 37,447 shares worth $17.7M. The position accounts for 0.07% of the portfolio, ranked #133.

Rathbones Group first reported a position in HCA in Q3 2023 and has held it in 11 quarters since. The position peaked at $19.3M in Q3 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Rathbones Group held 37,447 shares of HCA Healthcare worth $17.7M as of Q1 2026.
  • Rathbones Group sold 2,324 HCA Healthcare shares in Q1 2026, an estimated $1.17M.
  • HCA Healthcare made up 0.07% of Rathbones Group's portfolio in Q1 2026, its #133 holding.
  • Rathbones Group first reported a position in HCA Healthcare in Q3 2023 and has held it in 11 quarters since.
  • Rathbones Group's HCA Healthcare position peaked at $19.3M in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.